Overview

Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease

Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Active vitamin D at therapeutic dose may prevent vascular calcification but in supraphysiologic dose may precipitate it.
Phase:
Phase 2
Details
Lead Sponsor:
Ramathibodi Hospital
Treatments:
Alfacalcidol
Hydroxycholecalciferols